Lannett Company Inc. recalls Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: La
Recalled January 25, 2023 · FDA recall D-0160-2023 · Lannett
Hazard
Failed Impurity/Degradation Specifications · FDA Class III
Units
5,640 bottles
Sold at
Nationwide USA
Description
Failed Impurity/Degradation Specifications
Product
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10
Manufacturer(s)
Lannett Company Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →